Literature DB >> 11945156

The peptidase zymogen proregions: nature's way of preventing undesired activation and proteolysis.

Claude Lazure1.   

Abstract

Since the initial description of a peptidase activity, namely pepsin, in the middle of the 19(th) century, our understanding of the molecular basis of peptidase function and activation has greatly improved. Further, by sequencing entire genomes, we have reached a stage whereby it is now possible to appreciate the tremendous diversity and unique specificities of peptidases. Because of their importance in most if not all vital processes of the cell including ultimately its death, their activities must be carefully localized and kept under tight control. In addition to endogenous inhibitors, control of enzymatic activity can be achieved through their synthesis and transport as inactive zymogens. This review article will focus on the characteristics as well as the role of the proregion contained within the peptidase zymogen structure. It will survey novel zymogen structures determined in the past 5 years as well as those of selected emerging peptidase families for which there exists as yet no or little structural data. These include members belonging to the caspase, ADAMS, TTSP, MMP, Aspartyl peptidases and convertase families.

Mesh:

Substances:

Year:  2002        PMID: 11945156     DOI: 10.2174/1381612023395691

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  14 in total

1.  Identification of furin pro-region determinants involved in folding and activation.

Authors:  Lyne Bissonnette; Gabriel Charest; Jean-Michel Longpré; Pierre Lavigne; Richard Leduc
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.857

2.  Creation of a zymogen.

Authors:  Parit Plainkum; Stephen M Fuchs; Suthep Wiyakrutta; Ronald T Raines
Journal:  Nat Struct Biol       Date:  2003-02

3.  Thrombin-dependent MMP-2 activity is regulated by heparan sulfate.

Authors:  Bon-Hun Koo; Jung Ho Han; Young Il Yeom; Doo-Sik Kim
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

Review 4.  Inhibitors of proprotein convertases.

Authors:  Ajoy Basak
Journal:  J Mol Med (Berl)       Date:  2005-10-08       Impact factor: 4.599

5.  Site-directed mutagenesis and structural studies suggest that the germination protease, GPR, in spores of Bacillus species is an atypical aspartic acid protease.

Authors:  Thomas M Carroll; Peter Setlow
Journal:  J Bacteriol       Date:  2005-10       Impact factor: 3.490

6.  Synthetic peptides derived from the prosegments of proprotein convertase 1/3 and furin are potent inhibitors of both enzymes.

Authors:  Ajoy Basak; Claude Lazure
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

7.  Selective and potent furin inhibitors protect cells from anthrax without significant toxicity.

Authors:  Albert G Remacle; Katarzyna Gawlik; Vladislav S Golubkov; Gregory W Cadwell; Robert C Liddington; Piotr Cieplak; Sherri Z Millis; Roxane Desjardins; Sophie Routhier; Xue Wen Yuan; Witold A Neugebauer; Robert Day; Alex Y Strongin
Journal:  Int J Biochem Cell Biol       Date:  2010-03-01       Impact factor: 5.085

8.  A novel TMPRSS3 missense mutation in a DFNB8/10 family prevents proteolytic activation of the protein.

Authors:  Marie Wattenhofer; Nilüfer Sahin-Calapoglu; Ditte Andreasen; Ersan Kalay; Refik Caylan; Bastien Braillard; Nicole Fowler-Jaeger; Alexandre Reymond; Bernard C Rossier; Ahmet Karaguzel; Stylianos E Antonarakis
Journal:  Hum Genet       Date:  2005-07-14       Impact factor: 4.132

9.  A smallest 6 kda metalloprotease, mini-matrilysin, in living world: a revolutionary conserved zinc-dependent proteolytic domain- helix-loop-helix catalytic zinc binding domain (ZBD).

Authors:  Wei-Hsuan Yu; Po-Tsang Huang; Kuo-Long Lou; Shuan-Su C Yu; Chen Lin
Journal:  J Biomed Sci       Date:  2012-05-29       Impact factor: 8.410

10.  Identification of a small molecule that selectively inhibits mouse PC2 over mouse PC1/3: a computational and experimental study.

Authors:  Austin B Yongye; Mirella Vivoli; Iris Lindberg; Jon R Appel; Richard A Houghten; Karina Martinez-Mayorga
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.